Singapore markets open in 4 hours 21 minutes
Straits Times Index
3,303.66 +12.96 (+0.39%) S&P 500
5,221.42 -1.26 (-0.02%) Dow
39,431.51 -81.33 (-0.21%) Nasdaq
16,388.24 +47.37 (+0.29%) Bitcoin USD
63,089.47 +1,730.55 (+2.82%) CMC Crypto 200
1,296.51 +36.31 (+2.88%)
Iovance Biotherapeutics, Inc. (IOVA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.07B |
| Enterprise value | 2.86B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.17k |
| Price/book (mrq) | 5.25 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.31 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.65 |
| 52-week change 3 | 39.92% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 18.33 |
| 52-week low 3 | 3.21 |
| 50-day moving average 3 | 13.64 |
| 200-day moving average 3 | 8.50 |
Share statistics
| Avg vol (3-month) 3 | 9.02M |
| Avg vol (10-day) 3 | 6.02M |
| Shares outstanding 5 | 279.83M |
| Implied shares outstanding 6 | 279.83M |
| Float 8 | 211.43M |
| % held by insiders 1 | 0.54% |
| % held by institutions 1 | 89.21% |
| Shares short (30 Apr 2024) 4 | 50.06M |
| Short ratio (30 Apr 2024) 4 | 11.93 |
| Short % of float (30 Apr 2024) 4 | 19.96% |
| Short % of shares outstanding (30 Apr 2024) 4 | 17.89% |
| Shares short (prior month 28 Mar 2024) 4 | 46.38M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 26 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -16,464.61% |
Management effectiveness
| Return on assets (ttm) | -34.48% |
| Return on equity (ttm) | -66.77% |
Income statement
| Revenue (ttm) | 1.9M |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -451.03M |
| Net income avi to common (ttm) | -449.64M |
| Diluted EPS (ttm) | -1.89 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 356.2M |
| Total cash per share (mrq) | 1.27 |
| Total debt (mrq) | 84.37M |
| Total debt/equity (mrq) | 12.41% |
| Current ratio (mrq) | 4.63 |
| Book value per share (mrq) | 2.43 |
Cash flow statement
| Operating cash flow (ttm) | -384.28M |
| Levered free cash flow (ttm) | -231.84M |
© 2024 Yahoo. All rights reserved.